Navigation Links
Ellex Commences Direct Sales in Germany
Date:9/10/2008

ADELAIDE, Australia, Sept. 10 /PRNewswire/ -- Ellex Medical Lasers Limited (ASX: ELX) today announced another step in expanding its global reach with the establishment of a direct sales channel in Germany -- Ellex Deutschland GmbH.

To be formally launched at the European Society of Cataract and Refractive Surgeons (ESCRS) meeting in Berlin, 13-16 September 2008, Ellex Deutschland GmbH will focus initially on sales of Ellex laser products. Ellex's distribution partner for the Eye Cubed ultrasound product in Germany, M+C GmbH, will provide administration and logistical support for the new operations, allowing Ellex to establish a strong market position with minimal investment and reduced risk.

M+C have been active in the ophthalmic market for 20 years and have distributed the Eye Cubed since 1990. Their excellent reputation and strong sales and marketing network will be a significant benefit in establishing Ellex quickly in the German market. The partnership between Ellex and M+C will enable both companies to leverage common marketing channels and contacts. Plans include joint exhibits at German trade shows, promotional campaigns and educational workshops.

With over 8,000 ophthalmologists, Germany is one of the largest ophthalmic markets in the world. "The German market has significant potential and we look forward to working directly with ophthalmic surgeons throughout the region to demonstrate the quality of our products and our commitment to service. We are fortunate to have attracted experienced sales and service staff, and have the benefit of partnering with M+C, who have been our leading Eye Cubed distributor for many years," commented CEO Mr. Kevin McGuinness.

The first sales from the German operation are expected in September 2008. Ellex Deutschland GmbH will participate in its first official exhibition during the 2008 congress of the Deutsche Ophthalmologische Gesellschaft (DOG), which takes place immediately following the E
'/>"/>

SOURCE Ellex Medical Lasers Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO
2. MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada
3. Sun Pharma Commences All Cash Tender Offer to Purchase Taro Ordinary Shares for USD 7.75 Per Share
4. uKarma Corporation Commences International Distribution Agreement With Northern Response for its Xflowsion DVD Series
5. UltraShape(R) Commences Pivotal Study for First Non-Invasive Fat Reduction and Body Contouring Device Using Non-Thermal Selective Focused Ultrasound
6. China Sky One Medical, Inc. Commences Trading on the American Stock Exchange
7. Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium
8. SXC Health Solutions Corp. Commences Exchange Offer For Shares Of National Medical Health Card Systems, Inc.
9. Reckitt Benckiser Commences Cash Tender Offer for All Outstanding Shares of Adams Respiratory Therapeutics
10. Cytopia Commences Phase II Cancer Drug Study
11. Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., Unfair Labor Practices, Protecting Donors, ...Dec. 3 Teamsters who wo...lities in Philadelphia went on strike this morning...th working conditions at these facilities that cou...of the blood supply, not to mention the wellbeing ...
(Date:12/3/2009)... The Lifestyle Advisors at Virt...fts to ease the stress of finding that perfect gif... DIY treatments in health, fitness and wellness th...n time and within budget. , ... mySpaShop (mSS), has gathered an assortment of ...
(Date:12/3/2009)... Insightra Medical, Inc, a Cali...d the launch of its new ventral hernia repair syst...ard sublay technique, which completely obviates th... , (PRWEB) December 3, 200...dical device company today announced the launch of...
(Date:12/3/2009)... , YOUNGTOWN, Ariz., Dec. 3 /PRNewswire-First...announced today that it has acquired SunView Care ...,s campus in Youngtown, Arizona, a sister communit...ity. The acquisition was effective December 1, 200...rnh/20071213/LATH168LOGO ) ,, "We are pleased ...
(Date:12/3/2009)...ington, DC The study of tobacco has been the life..., MD, deputy director of the Lombardi Comprehensiv...enter, has led the effort to edit a special-editio... ( CEBP ) dedicated to best research practices in..., The December issue of CEBP , a journal of the...
Breaking Medicine News(10 mins):Health News:Philadelphia Red Cross Blood Workers Strike to Protect Donor and Blood Safety 2Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 2Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 3Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 4Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 2Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 4Health News:The Ensign Group Acquires Arizona Skilled Nursing Facility 2Health News:Lombardi's Shields leads special journal focused on tobacco research 2
...ments can cause harmful side effect when combined ...ic supplements reduced// blood levels of the saqui...hibitors that are effective at slowing the progres...ne healthy, HIV-negative volunteers received saqui...
...ading to an alarming rise in liver cirrhosis cases... after having increased in men for some time//, Pr...e adds that females are showing signs of permanent... from getting worse.Among 35 to 44-year-olds, ther...
...er vascular diseases are the leading causes of dea...iction of stenotic, occlusive, aneurismal, inflamm... angiography and digital subtraction angiography (...h a very high spatial resolution and temporal reso...
...d Drugs Department is beginning to bare its fangs ...ied pharmacists, an offence under the Indian Drugs...ial sources, not only does this common practice je...lified pharmacists. Since anyone with a couple of ...
...eight will grow up to be overweight adults isn't e...ody mass index in childhood is very often reflecte... thinnest as children and fattest as adults tended...til the age of 15 years. The researchers collected...
...o suffer from dementia benefit from music therapy....atients playing instruments and making music. The ... patients and can help them to communicate. ... sufferers. If their results are positive, the sci...
Other Medicine News:Health News:Magnetic resonance angiography in clinical medicine 2
(Date:12/3/2009)...hina, Dec. 3 /PRNewswire-Asia/ -- Simcere Pharmace... SCR ), a leading pharmaceutical company,specializ...ng of branded,generic and proprietary pharmaceutic...od and Drug Administration ("SFDA") has initiated ...regarding human use rabies vaccine (vero,cell) man...
(Date:12/3/2009)...NKI, December 3 After two decades ...their field, Lightlake Therapeutics, experts,have ...nd gene testing,subjects for a trial of a simple, ...alth Organisation has described as a global epidem...hase II trial for the everyday treatment against o...
(Date:12/2/2009).... 2 Reportlinker.com announces tha... catalogue: ,, Cardiac Pacemakers - A World M...m/p0164335/Cardiac-Pacemakers---A-World-Market-Ana...ajor segment in a rapidly expanding cardiovascular...market is characterized by relatively mature condi...
Breaking Medicine Technology:Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 4Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 5Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 2Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 3Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 4Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 5Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 6Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 7Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 8Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 9Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 10STEMCELL Technologies Inc Announces Release of Defined Animal Protein Free Maintenance Medium for hESCs and hiPSCs 59424 1STEMCELL Technologies Inc Announces Release of Defined Animal Protein Free Maintenance Medium for hESCs and hiPSCs 59424 2One Day Management Training Program to be Offered November 18 in Boston Area 59420 1One Day Management Training Program to be Offered November 18 in Boston Area 59420 2One Day Management Training Program to be Offered November 18 in Boston Area 59420 3One Day Management Training Program to be Offered November 18 in Boston Area 59420 4One Day Management Training Program to be Offered November 18 in Boston Area 59420 5New nanotech sensor developed with medical chemistry applications 14461 1New nanotech sensor developed with medical chemistry applications 14461 2
... Aug. 16 Cancer patients fraught with,flare-ups o...e assistance,in the form of a new easy-to-use oral...ences designed to quickly deliver pain medication....of pain: persistent and,breakthrough. Persistent c...sent for long periods of time, and often most of t...
... Two Presentations on the Topic of Drug Repurposin...rategy, MORRISTOWN, N.J., Aug. 16 Vicus Therapeu...opharmaceutical company, announced today,that Chie...ic Officer,Frederic Young, Ph.D., will each presen...Meeting on Sunday, August 19, 2007. The Meeting is...
Other Medicine Technology:Novel Technology Breaks Through Cancer Pain 2Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA 2Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA 3
...designed to improve the efficiency and quality of ...to capture and recall patient information whether ...n electronic health record application, it provide... compatible with all Microsoft Office applications...
...s developed expressly to help you manage the compl...nation of EMR software, clinical rules knowledge, ...s operating at peak performance. What's more, at..., our innovative Web-based revenue management syst...
...tion addresses every aspect of patient record-keep...inical care., The technology platform of Oaci... corethe first commercially viable CDR of its kind...ck connectivity and true interoperability among al...
...dular, Electronic Medical Record (EMR) system that...e a patient chart. ChartMaker is an EMR system th... medical reports, letters, and more. Pen-based, s...designed to be installed in a phased implementatio...
Medicine Products: